Two antibodies have been uncovered that are so effective at neutralizing COVID-19 — and all of its variants — that they believe the antibodies could serve as an “effective substitute for vaccines.”
The antibodies — TAU-1109 and TAU-2310 — bind to a different area of the spike protein than other antibodies, one that doesn’t undergo many mutations.
TAU-1109 is 92% effective at neutralizing the omicron strain and 90% effective at neutralizing the delta strain.
TAU-2310 has an efficacy rate of 84% at neutralizing omicron and a 97% efficacy rate against the delta variant.
The researchers believe that with effective antibody treatment, “we will not have to provide booster doses to the entire population every time there is a new variant.”